metastatic osteosarcoma

Known as: osteogenic sarcoma, metastatic, Osteosarcoma, Metastatic, Metastatic Osteogenic Sarcoma 
An osteosarcoma which has spread to another anatomical site.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Osteosarcoma (OS) remains the most common malignancy among orthopaedic neoplasms. Despite advanced surgical techniques and… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND The addition of liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) to chemotherapy has been shown to… (More)
Is this relevant?
2006
2006
BACKGROUND The outcome of patients with metastatic osteosarcoma treated in two consecutive trials from 1986 to 1997 was analyzed… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
PURPOSE To determine demographic data and define prognostic factors for long-term outcome in patients presenting with high-grade… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
PURPOSE The objectives of this trial were to estimate the response rate, progression-free survival, and overall survival of… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND In some malignancies, p53 mutations are associated with tumor progression. To address the role of p53 mutations in the… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
PURPOSE To estimate the duration of survival (S) of patients with metastatic osteosarcoma (MOS) at diagnosis treated with a… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
BACKGROUND A previous trial by the European Osteosarcoma Intergroup (EOI) suggested that a short intensive chemotherapy regimen… (More)
  • table 2
  • figure 1
  • table 1
  • table 5
  • table 4
Is this relevant?
Highly Cited
1993
Highly Cited
1993
The human homologue of the murine double minute 2 gene (MDM2), a p53-binding protein which may act as a regulator of p53 protein… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
BACKGROUND Neoadjuvant chemotherapy is the most accepted treatment for localized osteosarcoma. This has led to a great… (More)
Is this relevant?